These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4260264)

  • 21. Influence of L-3-methoxytyrosine on monoamine synthesis in rat brain.
    Kehr W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(4):347-56. PubMed ID: 1081656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo inhibition of dopamine beta-hydroxylase by 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624).
    Johnson GA; Boukma SJ; Kim EG
    J Pharmacol Exp Ther; 1970 Jan; 171(1):80-7. PubMed ID: 5410940
    [No Abstract]   [Full Text] [Related]  

  • 23. Levels of norepinephrine and dopamine in mouse brain regions following microwave inactivation--rapid post-mortem degradation of striatal dopamine in decapitated animals.
    Blank CL; Sasa S; Isernhagen R; Meyerson LR; Wassil D; Wong P; Modak AT; Stavinoha WB
    J Neurochem; 1979 Jul; 33(1):213-9. PubMed ID: 37287
    [No Abstract]   [Full Text] [Related]  

  • 24. Catechol- and indolamines in some endocrine cell systems. An autoradiographical, histochemical and radioimmunological study.
    Tjälve H
    Acta Physiol Scand Suppl; 1971; 360():1-122. PubMed ID: 4933514
    [No Abstract]   [Full Text] [Related]  

  • 25. (S)-norepinephrine in the tissues of mice and rats given racemic erythro-3,4-dihydroxyphenylserine (DOPS).
    Porter CC; Torchiana ML; Stone CA
    Life Sci I; 1972 Aug; 11(16):787-95. PubMed ID: 4540250
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of aminazin on the content of adrenaline, nordrenaline, dopamine and dopa in rat tissue in closed cranio-cerebral trauma].
    Matlina ESh; Rakhmanova TB
    Farmakol Toksikol; 1969; 32(2):138-40. PubMed ID: 5772133
    [No Abstract]   [Full Text] [Related]  

  • 27. Dopamine: mediator of brain polysome disaggregation after L-dopa.
    Weiss BF; Munro HN; Ordonez LA; Wurtman RJ
    Science; 1972 Aug; 177(4049):613-6. PubMed ID: 4403139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paper chromatographic identification of catecholamines.
    Laasberg LH; Shimosato S
    J Appl Physiol; 1966 Nov; 21(6):1929-34. PubMed ID: 5929329
    [No Abstract]   [Full Text] [Related]  

  • 29. 3-O-methyldopa, a new precursor of dopamine.
    Bartholini G; Kuruma I; Pletscher A
    Nature; 1971 Apr; 230(5295):533-4. PubMed ID: 4927759
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis of noradrenaline from 3,4-dihydroxyphenylalanine (DOPA) and dopamine in adrenergic nerves of mouse atrium--effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
    Jonsson G; Sachs C
    Acta Physiol Scand; 1970 Nov; 80(3):307-22. PubMed ID: 5486459
    [No Abstract]   [Full Text] [Related]  

  • 31. Methoxytyrosine formation as an indicator of catechol-O-methyltransferase activity in rat liver in vivo.
    Kehr W; Zimmermann R; Thiede M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):19-23. PubMed ID: 593428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of L-dopa administration of the concentrations of dopa, dopamine and norepinephrine in various rat tissues.
    Romero JA; Lytle LD; Ordonez LA; Wurtman RJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):67-72. PubMed ID: 4686016
    [No Abstract]   [Full Text] [Related]  

  • 33. CATECHOLAMINES, BIOSYNTHESIS AND INHIBITORS OF FORMATION.
    WEISS B; ROSSI GV
    Am J Pharm Sci Support Public Health; 1963 Jun; 135():206-18. PubMed ID: 14046042
    [No Abstract]   [Full Text] [Related]  

  • 34. SUBSTRATE SPECIFICITY OF DOPA DECARBOXYLASE.
    AWAPARA J; PERRY TL; HANLY C; PECK E
    Clin Chim Acta; 1964 Sep; 10():286-9. PubMed ID: 14205921
    [No Abstract]   [Full Text] [Related]  

  • 35. Early effects of 60 Co gamma-radiation on cerebral catecholamines, serotonin and related compounds.
    Păuşescu E; Chirvasie R; Teodosiu T; Lugojan R; Muntiu M
    Strahlentherapie; 1973 Jan; 145(1):76-82. PubMed ID: 4693342
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: a PET study with 6-[18F]L-DOPA.
    Doudet DJ; Chan GL; Holden JE; Pate BD; Morrison KS; Calne DB; Ruth TJ
    Eur J Pharmacol; 1997 Sep; 334(1):31-8. PubMed ID: 9346324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 40. Radioenzymatic assay of DOPA (3,4-dihydroxyphenylalanine).
    Johnson GA; Gren JM; Kupiecki R
    Clin Chem; 1978 Nov; 24(11):1927-30. PubMed ID: 709823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.